|
|
Article: German Biofrontera completes capital increase.
- Article from:
- ADP Debt News
- Article date:
- September 10, 2009
CopyrightCOPYRIGHT 2009 Aii Data Processing Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
(ADPnews) - Sep 10, 2009 - German biotechnology firm Biofrontera AG (ETR:B8F) has successfully completed a capital increase, which it initiated as part of the restructuring of its 8% convertible bond 2005/2010.
A total of 1.2 million shares were subscribed to at a share price of EUR 1.50 (USD 2.19), the company said yesterday.
With the capital hike and considering the ...